Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Finasteride helps reduce heart enlargement in heart failure patients.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Some blood thinners can cause hair loss, but switching medications can stop it.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Atropine and neosynephrine effectively prevent floppy iris syndrome during cataract surgery.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Correcting EDA fibronectin organization and YAP translocation can improve wound healing in fibrotic conditions.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.